A Form 4 filed on August 18, 2026 reports that David Schmidt, a director of Astrana Health, Inc. (NASDAQ:ASTH), exercised stock options and disposed of common stock on August 14, 2026.

Key Highlights

  • Option exercise: Schmidt exercised 20,000 stock options at an exercise price of $5 per share on August 14, 2026, acquiring 20,000 shares of common stock.
  • Shares disposed: 20,000 shares were disposed of at $38.59 per share on August 14, 2026, with the filing noting these shares were repurchased by the issuer.
  • Beneficial ownership after transactions: Schmidt directly beneficially owns 36,019 shares of common stock following the reported transactions.
  • Restricted stock included: The post-transaction total includes 4,525 shares of restricted stock, which vest on the earlier of June 10, 2027 or the date of the issuer's 2027 annual meeting of stockholders.
  • Options fully vested: According to the filing, the exercised stock options were fully vested and exercisable at the time of the transaction, and zero derivative securities remain held following the exercise.

Director Schmidt's Option Exercise and Share Disposition at Astrana Health

According to the filing, David Schmidt, identified as a director of Astrana Health, Inc., reported two transactions in common stock on August 14, 2026. First, Schmidt acquired 20,000 shares through the exercise of stock options (transaction code M) at an exercise price of $5 per share. The filing states these options were fully vested and exercisable, had an expiration date of September 14, 2026, and had a derivative security price of $0.

Second, the filing reports a disposition (transaction code D) of 20,000 shares at $38.59 per share on the same date. The filing explains in its responses that "these shares were repurchased by the Issuer," indicating the issuer, not an open-market buyer, was the counterparty to the disposal. Following both transactions, Schmidt's directly held beneficial ownership in common stock stands at 36,019 shares, according to the filing.

The filing further discloses that of those 36,019 shares, 4,525 are shares of restricted stock that will vest "on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders." The Form 4 was signed by Kathy Diep as attorney-in-fact on August 18, 2026, and was filed by one reporting person. No indirect ownership was reported.

What Was Disclosed

Astrana Health director David Schmidt reported exercising 20,000 fully vested stock options at $5 per share and disposing of 20,000 shares at $38.59 per share via issuer repurchase on August 14, 2026, leaving him with 36,019 directly held shares.